ArticleAntimicrobial agents and chemotherapy2017
Genomic and Molecular Characterization of Clinical Isolates of Enterobacteriaceae Harboring
Open access · bronzeAbstract read
In one paragraph
Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 9% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 61 citations in OpenAlex.
- Plasmid-mediated quinolone resistance (PMQR) among Enterobacteriales in Latin America: a systematic review.Molecular biology reports · 2020Pooled it
- Emergence and rapid global dissemination of CTX-M-15-associated Klebsiella pneumoniae strain ST307.The Journal of antimicrobial chemotherapy · 2019Pooled it
- The association between the genetic structures of commonly incompatible plasmids in Gram-negative bacteria, their distribution and the resistance genes.Frontiers in cellular and infection microbiology · 2024Review
- Antimicrobial resistance in food-associatedBioscience of microbiota, food and health · 2024Review
- A One Health approach based on genomics for enhancing theIJID regions · 2023Article
- Detection of Plasmid-Mediated Resistance against Colistin in Multi-Drug-Resistant Gram-Negative Bacilli Isolated from a Tertiary Hospital.Microorganisms · 2023Article
- Identification ofAntibiotics (Basel, Switzerland) · 2023Article
- Highly Sensitive and Specific Detection of Mobilized Colistin Resistance GeneMicrobiology spectrum · 2022Article
- Global colistin use: a review of the emergence of resistant Enterobacterales and the impact on their genetic basis.FEMS microbiology reviews · 2022Review
- Global epidemiology, genetic environment, risk factors and therapeutic prospects ofFrontiers in cellular and infection microbiology · 2022Review
- Genomic Characterization ofFrontiers in microbiology · 2022Article
- Carbapenemase Production and Detection of Colistin-Resistant Genes in Clinical Isolates ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2022Article
- Clinical Impact of Colistin Banning in Food Animal onFrontiers in microbiology · 2022Article
- Molecular Epidemiology of Extensively Drug-ResistantAntibiotics (Basel, Switzerland) · 2021Article
- Molecular Analysis of Polymyxin Resistance among Carbapenemase-ProducingAntibiotics (Basel, Switzerland) · 2021Article
- Mobile Colistin Resistance GeneMicroorganisms · 2021Article
- Article
- A Klebsiella pneumoniae ST307 outbreak clone from Germany demonstrates features of extensive drug resistance, hypermucoviscosity, and enhanced iron acquisition.Genome medicine · 2020Article
- Epigenomics, genomics, resistome, mobilome, virulome and evolutionary phylogenomics of carbapenem-resistantMicrobial genomics · 2020Article
- Emerging Antimicrobial-Resistant High-Risk Klebsiella pneumoniae Clones ST307 and ST147.Antimicrobial agents and chemotherapy · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 4 institutions in 2 countries.
Sandra Yamile SaavedraGrupo de Microbiología, Instituto Nacional de Salud (INS), Bogotá, Colombia sysaavedrar@gmail.com cduarte@ins.gov.co.
Lorena DiazMolecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogotá, Colombia.
Magdalena WiesnerGrupo de Microbiología, Instituto Nacional de Salud (INS), Bogotá, Colombia.
Adriana CorreaGrupo de Resistencia Bacteriana y Epidemiología Hospitalaria, International Center for Medical Research and Training (CIDEIM), Cali, Colombia.
Stefany Alejandra ArévaloGrupo de Microbiología, Instituto Nacional de Salud (INS), Bogotá, Colombia.
Jinnethe ReyesMolecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogotá, Colombia.
Andrea Melissa HidalgoGrupo de Microbiología, Instituto Nacional de Salud (INS), Bogotá, Colombia.
Elsa de la CadenaMolecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogotá, Colombia.
Marcela PerenguezGrupo de Resistencia Bacteriana y Epidemiología Hospitalaria, International Center for Medical Research and Training (CIDEIM), Cali, Colombia.
Lucy Angeline MontañoGrupo de Microbiología, Instituto Nacional de Salud (INS), Bogotá, Colombia.
Javier ArdilaMolecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogotá, Colombia.
Rafael RíosMolecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogotá, Colombia.
María Victoria OvalleGrupo de Microbiología, Instituto Nacional de Salud (INS), Bogotá, Colombia.
Paula DíazGrupo de Microbiología, Instituto Nacional de Salud (INS), Bogotá, Colombia.
Paola PorrasMolecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogotá, Colombia.
Maria V VillegasMolecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogotá, Colombia.
Cesar A AriasMolecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogotá, Colombia.
Mauricio BeltránDirección de Redes en Salud Pública y LNR, Instituto Nacional de Salud (INS), Bogotá, Colombia.
Carolina DuarteGrupo de Microbiología, Instituto Nacional de Salud (INS), Bogotá, Colombia sysaavedrar@gmail.com cduarte@ins.gov.co.
Instituto Nacional de Salud · COUniversidad El Bosque · COCentro Internacional de Entrenamiento e Investigaciones Medicas · COThe University of Texas Health Science Center at Houston · US
Funding
POR Program on Genomic Prediction of Antimicrobial Resistance in VREK24AI121296 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ARIAS, CESAR AUGUSTO · 2016 to 2025
$1.5MNIAID NIH HHS K24 AI121296
Abstract
Polymyxins are last-resort antimicrobial agents used to treat infections caused by carbapenem-resistant
Indexed as
Anti-Bacterial AgentsCarbapenemsColombiaDrug Resistance, BacterialEnterobacteriaceaeEscherichia coliEscherichia coli ProteinsHumansKlebsiella pneumoniaePlasmidsPolymyxinsRetrospective StudiesSalmonella typhimuriumAnti-Bacterial AgentsCarbapenemsEscherichia coli ProteinsMCR-1 protein, E coliPolymyxinsColombiaEnterobacteriaceaegenomicmcr-1
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.